Science Translational Medicine Journal Issues 5 Research Articles in Sept. 25, 2019 Edition
September 30, 2019
September 30, 2019
NEW YORK, Sept. 30 -- Science Translational Medicine, a peer-reviewed journal from the American Association for the Advancement of Science that focuses on research in the translational medicine community, published five research articles, including the following topics, in its Sept. 25, 2019 edition:
* CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
* Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
. . .
* CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
* Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
. . .